Table 3.
HF patients with low LVEF | HF patients with normal LVEF | Control subjects | p value | |
---|---|---|---|---|
(n = 25) | (n = 23) | (n = 21) | ||
TG/W (%) | 1.72 ± 2.63 | 1.18 ± 1.82 | 1.53 ± 1.78 | 0.68 |
FA/W (%) | 0.93 ± 2.13 | 0.97 ± 1.64 | 1.39 ± 1.67 | 0.66 |
UFA/W (%) | 0.79 ± 1.38*,** | 0.21 ± 0.28 | 0.14 ± 0.20 | 0.02 |
FA/TG (%) | 0.53 ± 0.41 | 0.68 ± 0.40 | 0.71 ± 0.32 | 0.25 |
UFA/TG (%) | 0.47 ± 0.41 | 0.32 ± 0.40 | 0.29 ± 0.32 | 0.25 |
Data are expressed as means ± standard deviation. P values are calculated from one-way analysis of variance
Abbreviations: HF heart failure, LVEF left ventricular ejection fraction, TG triglyceride; FA fatty acids, UFA unsaturated fatty acids, W water
* p < 0.05 vs. controls; ** p < 0.05 vs. HF patients with normal LVEF